Catalyst Wire Dossier Catalyst Wire Dossier

MR4-based immunosuppressive regimen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MR4-based immunosuppressive regimen, covering 2014-07-09 to 2014-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients [Phase 3]

See pricing